Population-screening tests such as bilateral screening mammography, FOBT, and PSA are highly recommended for the detection of pre-cancerous changes or early-stage breast, colorectal, and prostate cancers [28,29,30,31]. The gene discussed is KLK3; the disease is Familial prostate cancer.